Published in CMAJ on June 01, 1992
Accuracy of administrative databases in identifying patients with hypertension. Open Med (2007) 3.56
The economic burden of physical inactivity in Canada. CMAJ (2000) 3.51
Persistence with treatment for hypertension in actual practice. CMAJ (1999) 2.74
Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol (2007) 2.32
Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ (2000) 2.12
Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status. CMAJ (2000) 1.74
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2010) 1.44
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol (2009) 1.42
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. CMAJ (1999) 1.24
Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol (2008) 1.16
World Hypertension Day and global awareness. Can J Cardiol (2008) 1.15
The 2007 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update. Can J Cardiol (2007) 1.02
Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Can J Cardiol (2008) 1.01
Lifestyle changes to prevent and control hypertension: do they work? A summary of the Canadian consensus conference. CMAJ (1999) 0.99
Lifestyle approaches to managing high blood pressure. New Canadian guidelines. Can Fam Physician (1999) 0.98
Incidence of gestational hypertension in the Calgary Health Region from 1995 to 2004. Can J Cardiol (2009) 0.98
Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007. Cancer Causes Control (2014) 0.95
Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey. BMC Cardiovasc Disord (2005) 0.84
Cardiovascular disease risk factors and socioeconomic variables in a nation undergoing epidemiologic transition. BMC Public Health (2013) 0.83
2006 Ontario Survey on the Prevalence and Control of Hypertension (ON-BP): rationale and design of a community-based cross-sectional survey. Can J Cardiol (2008) 0.82
Heart and Stroke Foundation of Ontario (HSFO) high blood pressure strategy's hypertension management initiative study protocol. BMC Health Serv Res (2008) 0.78
The impact of a cardiovascular health awareness program (CHAP) on reducing blood pressure: a prospective cohort study. BMC Public Health (2013) 0.77
Awareness, attitude, and distribution of high blood pressure among health professionals. J Saudi Heart Assoc (2012) 0.76
Equipment errors: a prevalent cause for fallacy in blood pressure recording - a point prevalence estimate from an Indian health university. Indian J Community Med (2013) 0.75
Hypertension in Canada. Can Fam Physician (1999) 0.75
Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative. Clinicoecon Outcomes Res (2012) 0.75
[Hypertension. A new way to approach an old problem]. Can Fam Physician (1996) 0.75
An analysis of blood pressure measurement in a primary care hospital in Swaziland. Afr J Prim Health Care Fam Med (2014) 0.75
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ (1989) 4.76
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Recommendations from the Consensus Conference on Hypertension in the Elderly. CMAJ (1986) 3.06
Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ (1988) 2.36
Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol (1991) 2.18
Prevalence of cardiovascular disease risk factors in blacks and whites: the Minnesota Heart Survey. Am J Public Health (1988) 2.15
Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke (1990) 1.59
Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) (1985) 1.58
Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Comparisons of cohort and arteriography series analyses. Am J Epidemiol (1991) 1.53
Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med (1989) 1.49
Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr (1987) 1.30
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J (1990) 1.24
Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-1982 and 1985-1987. Am J Epidemiol (1990) 1.16
Factors associated with paradoxical survival at higher blood pressures in the very old. Am J Epidemiol (1991) 1.11
First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study. Can J Cardiol (1990) 1.07
The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. Am J Epidemiol (1988) 1.06
Blood pressure and mortality risk in the elderly. Am J Epidemiol (1991) 1.04
Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Intern Med (1978) 1.03
Cardiovascular risk factor change--1973-74 to 1980-82: the Minnesota Heart Survey. J Clin Epidemiol (1988) 1.01
Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial. Am J Med (1986) 0.99
The impact of elevated blood pressure upon 10-year mortality among Japanese men in Hawaii: the Honolulu Heart Program. J Chronic Dis (1983) 0.97
Antihypertensive drug treatment: the potential, expected and observed effects on vascular disease. J Hypertens Suppl (1990) 0.95
Coronary heart disease risk factors in a random sample of Athenian adults. The Athens Study. Am J Epidemiol (1987) 0.93
Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk. Am J Cardiol (1989) 0.93
Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J (1990) 0.91
Predictors of atherosclerosis in the Honolulu Heart Program. II. Adjustment for autopsy bias. Am J Epidemiol (1987) 0.91
Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens Suppl (1990) 0.90
Important risk factors for death in adults: a 10-year follow-up of the Nutrition Canada survey cohort. CMAJ (1987) 0.88
Relative weight and major ischaemic heart disease events in hypertensive men. Lancet (1989) 0.88
Antihypertensive drug therapy and survival by treatment status in a national survey. Hypertension (1989) 0.85
Risk factors related to ischemic and hemorrhagic cerebrovascular disease at autopsy: the Honolulu Heart Study. Stroke (1984) 0.85
Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women. Prev Med (1990) 0.84
Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings. Hypertension (1991) 0.82
[Hypertension consensus in The Netherlands]. Ned Tijdschr Geneeskd (1990) 0.82
Systolic Hypertension in the Elderly Program (SHEP). Part 5: Baseline blood pressure and pulse rate measurements. Hypertension (1991) 0.81
Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study. Am J Epidemiol (1988) 0.81
Awareness, treatment, and control of hypertension in Canada. Am J Hypertens (1997) 4.76
Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens (2001) 2.96
Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol (1977) 2.45
Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst (1980) 2.44
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ (1997) 2.41
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet (1994) 2.22
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med (1999) 1.87
Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. CMAJ (1993) 1.86
Where Manitoba children obtain their cigarettes. CMAJ (1987) 1.71
Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest (1996) 1.65
Early experience with laparoscopic approach for adrenalectomy. Surgery (1993) 1.61
The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ (1997) 1.61
Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun (1984) 1.59
Polysome-associated mRNAs are substrates for the nonsense-mediated mRNA decay pathway in Saccharomyces cerevisiae. RNA (1997) 1.58
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
Artificial sweeteners and human bladder cancer. Lancet (1977) 1.40
Evaluation of alternative calculation methods for determining LDL cholesterol. Vnitr Lek (2008) 1.38
The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett (1985) 1.36
Hyperkalemia-induced bundle branch block and complete heart block. Clin Cardiol (1981) 1.35
Influence of environmental temperature on the blood pressure of hypertensive patients in Montréal. Am J Hypertens (1991) 1.34
Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ (1993) 1.32
Chronobiology of cardiac sudden death in men. JAMA (1980) 1.30
Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension (2001) 1.30
Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev (2001) 1.30
Prepupal larval mosaics in Drosophila melanogaster. Nature (1976) 1.25
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord (1997) 1.24
The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res (2001) 1.24
Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry (1984) 1.19
Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.15
Ketone aldehydes in animal tissues. Proc Natl Acad Sci U S A (1967) 1.14
A minimal prevalence study of diagnosed diabetes in Newfoundland and Labrador. Can J Public Health (1991) 1.13
Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase. J Pharmacol Exp Ther (1983) 1.13
The assessment of student nurse learning styles using the Kolb Learning Styles Inventory. Nurse Educ Today (1995) 1.12
Whirlpool-associated folliculitis caused by Pseudomonas aeruginosa: report of an outbreak and review. J Clin Microbiol (1986) 1.12
Common variable immunodeficiency, Hodgkin's disease, and other malignancies in a Newfoundland family. Lancet (1975) 1.12
Prevalence of HIV infection among pregnant women in Newfoundland. CMAJ (1996) 1.10
Genetic determinants of hypertension: identification of candidate phenotypes. Hypertension (2000) 1.10
[Epidemiological profile of thyroid volume and disorders in Slovakia]. Vnitr Lek (2000) 1.10
Molecular characterization of the gene encoding the gamma subunit of the human skeletal muscle 1,4-dihydropyridine-sensitive Ca2+ channel (CACNLG), cDNA sequence, gene structure, and chromosomal location. J Biol Chem (1993) 1.09
Waisman syndrome, a human X-linked recessive basal ganglia disorder with mental retardation: localization to Xq27.3-qter. Genomics (1991) 1.09
Increased thyroid volume and prevalence of thyroid disorders in an area heavily polluted by polychlorinated biphenyls. Eur J Endocrinol (1998) 1.08
Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia. Am J Physiol (1991) 1.06
Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.05
Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet (2001) 1.05
Skeletal muscle and brain isoforms of a beta-subunit of human voltage-dependent calcium channels are encoded by a single gene. J Biol Chem (1992) 1.05
Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome. N Engl J Med (1999) 1.05
Shanghai trial of nifedipine in the elderly (STONE). J Hypertens (1996) 1.04
Cytosolic free magnesium in cardiac myocytes: identification of a Mg2+ influx pathway. Biochem Biophys Res Commun (1990) 1.04
Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med (1997) 1.04
Procedure to protect confidentiality of familial data in community genetics and genomic research. Clin Genet (1999) 1.04
A model of cardiac arrhythmias and sudden death: cantharidin-induced toxic cardiomyopathy. J Pharmacol Exp Ther (1979) 1.03
Brief report: two case studies using virtual reality as a learning tool for autistic children. J Autism Dev Disord (1996) 1.03
Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Intern Med (1978) 1.03
Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim Biophys Acta (2000) 1.02
Glomerular hyperfiltration in hypertensive African Americans. Hypertension (2000) 1.01
Effect of chronic infusion of synthetic atrial natriuretic factor (ANF 8-33) in conscious two-kidney, one-clip hypertensive rats. Proc Soc Exp Biol Med (1985) 1.00
Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr (1991) 0.99
Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Differ (1999) 0.98
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. Hypertension (1999) 0.97
Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Kidney Int (2006) 0.97
Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens (1999) 0.97
Dinucleotide repeat polymorphism at the D17S518 locus. Nucleic Acids Res (1991) 0.97
Cyclic GMP in cell function. Adv Second Messenger Phosphoprotein Res (1988) 0.97
The influence of dairy products on plasma uric acid in women. Eur J Epidemiol (1995) 0.96
Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension (1989) 0.96
Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab (2001) 0.96
Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care (2000) 0.96
Dynamics of intracellular free Mg2+ changes in a vascular smooth muscle cell line. Am J Physiol (1993) 0.96
The electrocardiogram in apparently healthy men and the risk of sudden death. Br Heart J (1982) 0.95
Intracellular monovalent ions as second messengers. J Membr Biol (2006) 0.94
Prazosin plasma concentration and blood pressure reduction. Hypertension (1982) 0.94
Cyclic GMP as mediator and biological marker of atrial natriuretic factor. J Hypertens Suppl (1986) 0.94
Inversion of the intracellular Na+/K+ ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J Biol Chem (1999) 0.94
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension (2000) 0.94
Technique for determining the bactericidal effect of drug combinations. Antimicrob Agents Chemother (1974) 0.93
Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther (1994) 0.93
Refined genetic localization for central core disease. Am J Hum Genet (1993) 0.93
Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins (1977) 0.93
Local anesthetic myotoxicity: a case and review. Anesthesiology (1994) 0.92
Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. J Clin Endocrinol Metab (1985) 0.92
Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema. J Clin Endocrinol Metab (1975) 0.91
Mapping of quantitative trait loci (QTL) of differential stress gene expression in rat recombinant inbred strains. J Hypertens (2000) 0.91
Predictors of target organ damage in hypertensive blacks and whites. Hypertension (2001) 0.90
Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension (2000) 0.90
HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation. J Biol Chem (2000) 0.90
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ (1997) 0.90
The relation of blood pressure to stroke prognosis. Ann Intern Med (1978) 0.90
Relationship of ventricular ectopy in men without apparent heart disease to occurrence of ischemic heart disease and sudden death. Am Heart J (1981) 0.90